New NIP shingles vaccine boosts uptake, Mayne Pharma trims board, Montu to hit the heights for rare cancers, and more
Click here to download Pharmacy Daily for Thursday 15th January 2026
PARTNER SITES
Other recent headlines
-
Boost to shingles vax uptake
Thursday | Jan 15 2026THE introduction of a two-dose schedule of Shingrix (recombinant protein subunit) herpes zoster vaccine on the National Immunisation Program (NIP) in Nov 2023 has resulted in a 40% increase in vaccination in Australians aged 65 , according to the National Centre for Immunisation Research and Surveillance (NCIRS).
-
Montu climbing mountains
Thursday | Jan 15 2026MONTU has confirmed it will again take part in the Kosi Challenge, with a team drawn from across Montu’s clinical, operational and corporate functions – including chief executive officer Myles Lawlor – to climb Mount Kosciuszko, raising funds and awareness for Australians living with rare, less common and complex cancers.
-
Recreational drugs driving overdoses
Wednesday | Jan 14 2026CLINICAL toxicologists in Queensland have reported that overdoses from recreational drugs have increased over the last 10 years, with methamphetamine intoxication taking over from paracetamol to become the most common toxicological presentation at the Emergency Department.
to top